- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02797106
Management of Drooling in Children With Cerebral Palsy in France (TOXSIALO)
June 10, 2016 updated by: Hospices Civils de Lyon
Management of Drooling in Children With Cerebral Palsy: A French Survey of the Practices and Opinions of Health Professionals
The study is a transversal, observational, descriptive survey of the practices and opinions of health professionals carried out nationally across France that aims to characterize children with cerebral palsy and pathological drooling and to describe care pathways, assessment and treatment of drooling.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
400
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
health care professionals potentially involved in assessment and/or treatment of drooling in children with Cerebral Palsy.
Description
Inclusion Criteria:
- health professional known to assess and/or treat drooling
- health professional known to assess and/or treat children with Cerebral Palsy
- health professional exercising in France
Exclusion Criteria:
- health professional with an inactive e-mail address
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
health care professionals
health care professionals potentially involved in assessment and/or treatment of drooling in children with Cerebral Palsy.
|
Survey of the practices and opinions of health care professionals to describe care pathways, assessment and treatment of drooling in children with cerebral palsy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire on the assessment and treatment of drooling in children with Cerebral Palsy
Time Frame: Day 1 (At the time of the questionnaire mailing to the professionals)
|
Questionnaire will measure practices of health professionals involved in care pathways, assessment and treatment of drooling in children with Cerebral Palsy.
|
Day 1 (At the time of the questionnaire mailing to the professionals)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Emmanuelle CHALEAT-VALAYER, MD, CMCR des Massues -Croix Rouge Française, Lyon
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
May 31, 2016
First Submitted That Met QC Criteria
June 10, 2016
First Posted (Estimate)
June 13, 2016
Study Record Updates
Last Update Posted (Estimate)
June 13, 2016
Last Update Submitted That Met QC Criteria
June 10, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D21660
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.